TCL Archive Bertagnolli: Why Brigham Stopped Making Morcellation Available Outside Of A Registry Trial July 4, 2014
TCL Archive Natcher: Multiple Year Funding Would Not be Approved If Presented As Request For Reprogramming March 22, 1985
TCL Archive FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March. January 21, 2005
TCL Archive Cancer Deaths Level Off For First Time, Klausner Tells House Appropriators. February 18, 2000
TCL Archive Conversation with The Cancer Letter: McKinsey Charge: Create Plan To Expand MD Anderson’s Reach February 7, 2014
